A brief review of biomarkers for preventing and treating cardiovascular diseases
- PMID: 23233766
- PMCID: PMC3516002
- DOI: 10.4103/0975-3583.102688
A brief review of biomarkers for preventing and treating cardiovascular diseases
Abstract
Cardiovascular diseases are the most prominent circulation disorders around the world. Biomarkers are characteristic biological properties that can be objectively measured as an indicator to evaluate a variety of health or disease characteristics. Cardiac biomarkers are a valuable tool for assessing the pathogenesis and diagnosis of cardiovascular diseases. In this review, we will focus on the major biomarkers used in recent clinical research for the diagnosis of cardiovascular diseases, which include mean platelet volume, hyperhomocysteinemia, serum magnesium, microalbuminuria, and prolongation of QT interval and dispersion. We also highlight the key findings of clinical case report based studies presented in this issue of JCDR.
Keywords: Biomarkers; cardiovascular diseases; pathogenesis.
Conflict of interest statement
Similar articles
-
Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.Clin Sci (Lond). 1997 Oct;93(4):325-33. doi: 10.1042/cs0930325. Clin Sci (Lond). 1997. PMID: 9404224
-
The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens.Eur Heart J. 1998 Sep;19(9):1391-400. doi: 10.1053/euhj.1998.1094. Eur Heart J. 1998. PMID: 9792266 Clinical Trial.
-
The comparison of QT dispersion and 24 hour ambulatory blood pressure monitoring amongst diabetic patients with and without microalbuminuria.Med J Malaysia. 2004 Jun;59(2):185-9. Med J Malaysia. 2004. PMID: 15559168
-
Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular risk.Curr Vasc Pharmacol. 2010 Sep;8(5):604-11. doi: 10.2174/157016110792006914. Curr Vasc Pharmacol. 2010. PMID: 20507275 Review.
-
Assessing QT interval prolongation and its associated risks with antipsychotics.CNS Drugs. 2011 Jun 1;25(6):473-90. doi: 10.2165/11587800-000000000-00000. CNS Drugs. 2011. PMID: 21649448 Review.
Cited by
-
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1.J Neurol. 2023 Jun;270(6):3138-3158. doi: 10.1007/s00415-023-11633-1. Epub 2023 Mar 9. J Neurol. 2023. PMID: 36892629
-
Reply to the letter "Mean platelet volume as a surrogate marker of inflammation in systemic lupus erythematosus".Clin Rheumatol. 2014 Nov;33(11):1693. doi: 10.1007/s10067-014-2591-5. Epub 2014 May 4. Clin Rheumatol. 2014. PMID: 24794487 No abstract available.
-
Detection of Cardiovascular Disease Risk's Level for Adults Using Naive Bayes Classifier.Healthc Inform Res. 2016 Jul;22(3):196-205. doi: 10.4258/hir.2016.22.3.196. Epub 2016 Jul 31. Healthc Inform Res. 2016. PMID: 27525161 Free PMC article.
-
Microextraction by Packed Sorbent (MEPS) and Solid-Phase Microextraction (SPME) as Sample Preparation Procedures for the Metabolomic Profiling of Urine.Metabolites. 2014 Jan 27;4(1):71-97. doi: 10.3390/metabo4010071. Metabolites. 2014. PMID: 24958388 Free PMC article.
-
Comparison of mobile apps for the leading causes of death among different income zones: a review of the literature and app stores.JMIR Mhealth Uhealth. 2014 Jan 9;2(1):e1. doi: 10.2196/mhealth.2779. JMIR Mhealth Uhealth. 2014. PMID: 25099695 Free PMC article. Review.
References
-
- WHO. Cause-specific mortality, 2008. World Health Organization 2008. Accessed on July 25, 2012 from: http://www.who.int/gho/mortality_burden_disease/global_burden_disease_DT... .
-
- Berenson GS, Srinivasan SR, Hunter SM, Nicklas TA, Freedman DS, Shear CL, et al. Risk factors in early life as predictors of adult heart disease: The Bogalusa Heart Study. Am J Med Sci. 1989;298:141–51. - PubMed
-
- Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth: The PDAY study. Pediatr Pathol Mol Med. 2002;21:213–37. - PubMed